AI disruption fears have eased for Indian IT, but global growth concerns, inflation and Middle East tensions continue to weigh on the outlook, says Dolat Capital.

Fintel reports that on 7 October 2026, Barclays initiated coverage of Boston Scientific (WBAG:BSXC) with a Equal-Weight recommendation. This rating action is recorded alongside a prior action by the ...

Asian shares slipped on Thursday as strains in sovereign bond markets were aggravated by reports some major tech companies were seeking to raise billions in debt in direct competition for limited ...

Fintel reports that on 7 October 2026, UBS upgraded their outlook for Moelis (DB:17M) from Sell to Neutral. This rating action follows a prior action by UBS on 8 July 2026, when the firm downgraded ...